Questran 4 g Noruega - noruego - Statens legemiddelverk

questran 4 g

cheplapharm arzneimittel gmbh - kolestyramin - pulver til mikstur, suspensjon - 4 g

Valcyte 50 mg/ ml Noruega - noruego - Statens legemiddelverk

valcyte 50 mg/ ml

cheplapharm arzneimittel gmbh - valganciklovirhydroklorid - pulver til mikstur, oppløsning - 50 mg/ ml

Dimethyl fumarate Glenmark 240 mg Noruega - noruego - Statens legemiddelverk

dimethyl fumarate glenmark 240 mg

glenmark arzneimittel gmbh - dimetylfumarat - enterokapsel, hard - 240 mg

Dimethyl fumarate Glenmark 120 mg Noruega - noruego - Statens legemiddelverk

dimethyl fumarate glenmark 120 mg

glenmark arzneimittel gmbh - dimetylfumarat - enterokapsel, hard - 120 mg

Insulin Human Winthrop Unión Europea - noruego - EMA (European Medicines Agency)

insulin human winthrop

sanofi-aventis deutschland gmbh - insulin human - sukkersyke - legemidler som brukes i diabetes - diabetes mellitus hvor behandling med insulin er nødvendig. insulin human winthrop rapid er også egnet for behandling av hyperglykemisk koma og ketoacidose, samt for å oppnå pre-, intra- og postoperativ stabilisering hos pasienter med diabetes mellitus.

Rosuvastatin Glenmark 40 mg Noruega - noruego - Statens legemiddelverk

rosuvastatin glenmark 40 mg

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 40 mg

Rosuvastatin Glenmark 5 mg Noruega - noruego - Statens legemiddelverk

rosuvastatin glenmark 5 mg

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 5 mg

Rosuvastatin Glenmark 10 mg Noruega - noruego - Statens legemiddelverk

rosuvastatin glenmark 10 mg

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 10 mg

Rosuvastatin Glenmark 20 mg Noruega - noruego - Statens legemiddelverk

rosuvastatin glenmark 20 mg

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 20 mg

Sapropterin Dipharma Unión Europea - noruego - EMA (European Medicines Agency)

sapropterin dipharma

dipharma arzneimittel gmbh - sapropterin dihydrochloride - phenylketonurias - andre alimentary tract and metabolism products, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.